This item reaches 7,574 million euros from January to November 2021.

This item reaches 7,574 million euros from January to November 2021.

This item reaches 7,574 million euros from January to November 2021.

Two doctors with a patient in the ICU.

Although the omicron variant did not appear until the end of November 2021, the truth is that the incidence of Covid-19 in Spain and the occupation of beds began to increase throughout that month. Some climbs that marked the start of the sixth wave of infections.

Between November 2 and 30, the occupation of beds by Covid went from 1.42% to 3.10%. Regarding ICUs, it went from 4.4% to 7.76%. It was precisely in November when a almost 7% increase in hospital spendingaccording to the latest pharmaceutical spending figures published by the Ministry of Finance.

This is the highest growth of 2021, raising this item to 7,574 million euros in the accumulated from January to November. Only the months of January, February and March fell in this item, with respect to the figures of the previous year.

But, starting in April, hospital spending has shown increases ranging from 2% (April) to 6.9% (November). Thus, comparing the figures for November 2020 with those for 2021, this item has grown by 488 million euros, always according to data from the Ministry of Finance.

But it is not the only one that goes up. She does too prescription health products: 7.2% in November. Thus, this expense reaches 11,416 million euros in the accumulated from January to November 2021.

Spending on Covid products

As we have been counting in recent months in EL ESPAÑOL-Invertia, spending on products associated with Covid-19 has been decreasing throughout the year. Until November, this item amounts to 889.5 million euros.

For their part, in the same period of 2020, the State and the autonomous communities had allocated 2,288 million euros to products associated with the coronavirus. Namely, this expense falls by almost 1,400 million euros.

A doctor treats a coronavirus patient.

A doctor treats a coronavirus patient.

This drop is also reflected in spending on non-prescription health products (including Covid products). Specifically, this item is reduced by 9.8% thanks, precisely, to the decrease in spending on products associated with the coronavirus.

On the other hand, if we exclude these products, this item increases by 20.4% in November, rising to 4,678 million euros.

Taking into account all these games, Pharmaceutical expenditure in Spain grew by 2.7%, reaching 24,559 million euros between January and November 2021. Of this total, 24,101 million correspond to spending by the autonomous communities, while the remaining 458 million correspond to the State.

Adminartua

Leave a Reply

Your email address will not be published.